When hospitals evaluate transesophageal echocardiography (TEE) probe reprocessing systems, the first comparison is usually capital cost.

What is the purchase price?
What is the discount?
What is the lease structure?

But in high-level disinfection, capital expenditure is only a fraction of the financial equation.

The more important question is:

What does your current TEE disinfection process cost you every year and what will it cost over 10 years?

Capital Cost Is a Line Item. Total Cost of Ownership Is a Strategy.

Manual and chemical high-level disinfection systems often appear financially attractive because the upfront device cost is modest.

However, the device price is not the primary economic driver.

The recurring operational burden is.

A true financial evaluation of TEE reprocessing should include:

• Chemical disinfectants
• Test strips and concentration monitoring
• Neutralizers
• Personal protective equipment
• Hazardous waste handling
• Staff time per cycle
• Documentation management
• Repeat or rework cycles
• Throughput delays
• Equipment repair costs

These are recurring costs that scale with procedure volume. Over time, they frequently exceed the initial capital investment.

The D60 and the Shift to Lifecycle Economics

The UV Smart D60 was developed specifically for automated, UV-C high-level disinfection of TEE probes. Its financial relevance is not just about replacing chemicals, it is about restructuring the cost model of reprocessing.

Instead of a consumable-dependent workflow, the D60 introduces:

• Fixed, validated UV-C disinfection cycles
• No chemical disinfectants
• No concentration testing
• No hazardous chemical waste
• Digital traceability and cycle documentation

This fundamentally changes how cost per cycle is calculated.

Breaking Down Total Cost of Ownership in TEE Reprocessing

1. Consumables Burden

Chemical-based systems require recurring purchases tied directly to procedure volume.

As TEE utilization increases, whether due to structural heart programs, interventional cardiology expansion, or surgical growth, consumable cost rises proportionally.

With the D60, there are no chemical disinfectants to replenish, no test strips to manage, and no chemical disposal requirements. Operating costs become more predictable and less sensitive to procedural growth.

2. Labor Dependency

Manual high-level disinfection requires active oversight:

• Monitoring soak duration
• Performing concentration checks
• Manual documentation
• Managing PPE compliance

These steps consume staff time per cycle.

Labor is one of the fastest-growing expenses in healthcare. Even small time differences per reprocessing cycle, multiplied across daily TEE volume and annual operating days, create meaningful financial impact.

By automating and standardizing the cycle, the D60 reduces variability in hands-on time and shifts the process from labor-intensive to workflow-controlled.

3. Variability and Rework

Manual processes introduce variability.

Missed soak times.
Expired concentration levels.
Incomplete documentation.
Repeat cycles due to uncertainty.

Each instance may seem minor, but collectively they introduce operational friction and hidden cost.

A validated, fixed UV-C cycle removes many of these variability factors and supports more consistent documentation, which is increasingly important in audit-conscious environments.

4. Throughput and Operational Predictability

TEE probes are critical assets. When reprocessing delays occur, they influence:

• Case scheduling
• OR turnover
• Cardiology lab efficiency
• Staff overtime

Operational predictability has financial value.

A structured cost analysis must consider whether the current reprocessing method supports procedural growth or constrains it.

A Practical Financial Question

Rather than asking:

“What does the D60 cost?”

Hospitals should ask:

• What is our current cost per TEE disinfection cycle?
• What is our annual consumables spend?
• How much staff time is tied to reprocessing?
• What does repeat processing cost us each year?
• What is our 10-year operational exposure?
• What do we spend on damaged equipment per year?

When viewed over a 10-year lifecycle, the economics of TEE disinfection look very different than a simple capital comparison.

Why a Customized Cost Analysis Matters

Every cardiology department is different.

Procedure volume.
Probe inventory.
Staffing model.
Documentation workflow.
Growth projections.

A surface-level comparison cannot capture those nuances.

That is why UV Smart supports hospitals with structured, department-specific cost evaluations comparing current chemical workflows to the D60 model.

A customized analysis can provide clarity on:

• Current annual reprocessing cost
• 10-year total cost of ownership
• Estimated cost per procedure
• Consumables exposure
• Labor allocation impact

This supports procurement discussions with real data, not assumptions.

For Procurement and Financial Leaders

If you are evaluating TEE reprocessing systems this year, consider moving beyond capital price comparison.

Assess:

• Lifecycle cost
• Labor dependency
• Consumables burden
• Operational variability
• Throughput impact

Understanding total cost of ownership provides a stronger financial foundation for decision-making.

👉 Request a customized five and 10-year cost analysis for your department.

For Cardiology Leadership

TEE is central to procedural efficiency. Reprocessing reliability influences clinical flow and scheduling confidence.

A structured financial evaluation strengthens your position in capital planning conversations.

👉 Schedule a D60 financial impact review tailored to your department.

The Bottom Line

Capital cost is visible.

Operational cost is persistent.

Evaluating TEE disinfection through a total cost of ownership lens transforms the conversation from device comparison to economic strategy.

If you would like to understand what your current TEE reprocessing workflow truly costs, and how the D60 may change that model, we invite you to begin with a customized financial assessment.

👉 Connect with UV Smart to build your department-specific cost analysis.

‍